Must See: Do You Invest in Midcap Stocks? Here's a Great News for You
Here is the latest financial fact sheet of LAURUS LABS . For more details, see the LAURUS LABS quarterly results and LAURUS LABS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -0.3 |
No. of shares | m | 538.97 |
1 Week | % | -4.5 |
1 Month | % | 10.4 |
1 Year | % | 44.8 |
52 week H/L | Rs | 470.9/279.7 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
LAURUS LABS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 520 | 460 | 1,550 | 724 | 626 | |
Low | Rs | 324 | 298 | 251 | 361 | 287 | |
Sales per share (Unadj.) | Rs | 215.3 | 264.9 | 89.7 | 91.8 | 112.1 | |
Earnings per share (Unadj.) | Rs | 8.8 | 23.9 | 18.3 | 15.5 | 14.8 | |
Diluted earnings per share | Rs | 1.7 | 4.7 | 18.3 | 15.4 | 14.8 | |
Cash flow per share (Unadj.) | Rs | 24.2 | 41.4 | 22.2 | 20.2 | 20.8 | |
Dividends per share (Unadj.) | Rs | 0.30 | 0.50 | 2.00 | 2.00 | 2.00 | |
Adj. dividends per share | Rs | 0.06 | 0.10 | 1.99 | 1.99 | 2.00 | |
Avg Dividend yield | % | 0.1 | 0.1 | 0.2 | 0.4 | 0.4 | |
Book value per share (Unadj.) | Rs | 145.9 | 165.1 | 48.3 | 62.2 | 74.7 | |
Adj. book value per share | Rs | 28.8 | 32.8 | 48.1 | 62.0 | 74.7 | |
Shares outstanding (eoy) | m | 106.44 | 106.91 | 536.60 | 537.36 | 538.65 | |
Price / Sales ratio | x | 2.0 | 1.4 | 10.0 | 5.9 | 4.1 | |
Avg P/E ratio | x | 47.9 | 15.9 | 49.1 | 35.0 | 30.9 | |
P/CF ratio (eoy) | x | 17.4 | 9.2 | 40.6 | 26.9 | 21.9 | |
Price / Book Value ratio | x | 2.9 | 2.3 | 18.6 | 8.7 | 6.1 | |
Dividend payout | % | 3.4 | 2.1 | 10.9 | 12.9 | 13.5 | |
Avg Mkt Cap | Rs m | 44,916 | 40,521 | 483,157 | 291,289 | 245,840 | |
Total wages/salary | Rs m | 2,763 | 3,208 | 3,970 | 4,696 | 5,574 |
LAURUS LABS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 22,919 | 28,317 | 48,135 | 49,356 | 60,406 | |
Other income | Rs m | 162 | 59 | 237 | 153 | 60 | |
Total revenues | Rs m | 23,081 | 28,376 | 48,372 | 49,509 | 60,466 | |
Gross profit | Rs m | 3,560 | 5,646 | 15,507 | 14,224 | 15,922 | |
Depreciation | Rs m | 1,642 | 1,873 | 2,051 | 2,515 | 3,241 | |
Interest | Rs m | 882 | 896 | 682 | 1,024 | 1,652 | |
Profit before tax | Rs m | 1,198 | 2,936 | 13,011 | 10,839 | 11,089 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 260 | 383 | 3,173 | 2,514 | 3,123 | |
Profit after tax | Rs m | 938 | 2,553 | 9,838 | 8,324 | 7,966 | |
Gross profit margin | % | 15.5 | 19.9 | 32.2 | 28.8 | 26.4 | |
Effective tax rate | % | 21.7 | 13.1 | 24.4 | 23.2 | 28.2 | |
Net profit margin | % | 4.1 | 9.0 | 20.4 | 16.9 | 13.2 |
LAURUS LABS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 14,630 | 18,121 | 30,749 | 33,446 | 34,617 | |
Current liabilities | Rs m | 14,239 | 16,924 | 24,572 | 26,810 | 24,323 | |
Net working cap to sales | % | 1.7 | 4.2 | 12.8 | 13.4 | 17.0 | |
Current ratio | x | 1.0 | 1.1 | 1.3 | 1.2 | 1.4 | |
Inventory Days | Days | 12 | 9 | 11 | 12 | 14 | |
Debtors Days | Days | 113 | 10 | 10 | 10 | 10 | |
Net fixed assets | Rs m | 18,148 | 18,643 | 26,758 | 36,234 | 41,987 | |
Share capital | Rs m | 1,064 | 1,069 | 1,073 | 1,075 | 1,077 | |
"Free" reserves | Rs m | 14,466 | 16,582 | 24,853 | 32,346 | 39,177 | |
Net worth | Rs m | 15,530 | 17,651 | 25,926 | 33,420 | 40,255 | |
Long term debt | Rs m | 2,587 | 1,650 | 4,292 | 5,963 | 7,614 | |
Total assets | Rs m | 32,778 | 36,764 | 57,507 | 69,680 | 76,604 | |
Interest coverage | x | 2.4 | 4.3 | 20.1 | 11.6 | 7.7 | |
Debt to equity ratio | x | 0.2 | 0.1 | 0.2 | 0.2 | 0.2 | |
Sales to assets ratio | x | 0.7 | 0.8 | 0.8 | 0.7 | 0.8 | |
Return on assets | % | 5.6 | 9.4 | 18.3 | 13.4 | 12.6 | |
Return on equity | % | 6.0 | 14.5 | 37.9 | 24.9 | 19.8 | |
Return on capital | % | 11.5 | 19.9 | 45.3 | 30.1 | 26.6 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 34.3 | 35.0 | 34.4 | 26.7 | 22.7 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 7,860 | 9,909 | 16,560 | 13,170 | 13,720 | |
Fx inflow | Rs m | 11,561 | 19,299 | 33,250 | 34,370 | 43,470 | |
Fx outflow | Rs m | 7,860 | 9,909 | 16,560 | 13,170 | 13,720 | |
Net fx | Rs m | 3,701 | 9,390 | 16,690 | 21,200 | 29,750 |
LAURUS LABS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 2,977 | 3,474 | 7,330 | 9,111 | 9,939 | |
From Investments | Rs m | -2,529 | -2,211 | -9,410 | -9,143 | -9,961 | |
From Financial Activity | Rs m | -448 | -1,277 | 2,547 | 303 | -266 | |
Net Cashflow | Rs m | -0 | -13 | 468 | 269 | -297 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: M Venu Gopala Rao | COMP SEC: G Venkateswar Reddy | YEAR OF INC: 2005 | BSE CODE: 540222 | FV (Rs): 2 | DIV YIELD (%): 0.5 |
Read: LAURUS LABS 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Compare LAURUS LABS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES SUN PHARMA CIPLA
Indian share markets Slipped further as the session progressed and ended the day weak.